Limits...
Prognosis of sepsis induced by cecal ligation and puncture in mice improved by anti-Clonorchis Sinensis cyclopholin a antibodies.

Song T, Yang M, Chen J, Huang L, Yin H, He T, Huang H, Hu X - Parasit Vectors (2015)

Bottom Line: Lung and mesentery tissues were stained with hematoxylin-eosin.Anti-CsCyPA antibodies could combine with MuCyPA and inhibit its peptidyl prolyl isomerase (PPIase) activity.Furthermore, the survival rate was elevated, ranging from 10.0 % to 45.0 % compared to the control group.

View Article: PubMed Central - PubMed

Affiliation: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. songtianzhang@163.com.

ABSTRACT

Background: Cyclophilin A (CyPA), a ubiquitously distributed intracellular protein, is thought to be one of the important inflammatory factors and plays a significant role in the development process of sepsis. In the form of cytokine, CyPA deteriorates sepsis by promoting intercellular communication, apoptosis of endothelial cells and chemotactic effect on inflammatory cells. In our previous study, cyclophilin A of Clonorchis sinensis (CsCyPA), a type of excretory-secretory antigen, could induce the patients infected with Clonorchis sinensis to produce specific anti-CsCyPA antibodies. In this study, we investigated whether anti-CsCyPA antibodies could cross-react with CyPA and then play a protective role against sepsis, just like other anti-cytokine antagonists.

Methods: The mice model with sepsis was established with cecal ligation and puncture (CLP). Fifty mg/kg purified anti-CsCyPA antibodies were injected via the caudal vein 6 h after the CLP operation, and persistent observation was performed for 72 h. Blood samples and tissues were collected at 6 h, 12 h, 24 h, 48 h and 72 h after CLP. Cytokines in serum were measured by ELISA. Lung and mesentery tissues were stained with hematoxylin-eosin. Endothelial cells (ECs) isolated from murine aorta were co-cultured with CyPA of mice (MuCyPA) and anti-CsCyPAs for 24 h, then, viability was measured by Cell Counting Kit-8.

Results: Anti-CsCyPA antibodies could combine with MuCyPA and inhibit its peptidyl prolyl isomerase (PPIase) activity. In the antibodies treatment group, blood coagulation indicators including PT, aPTT, D-dimer and platelet count were obviously more ameliorative, the proinflammary factors like IL-6, TNF-α, IL-1β were significantly lower at 12 h and 24 h after surgery and the viability of ECs was significantly improved compared to those in the control group. Furthermore, the survival rate was elevated, ranging from 10.0 % to 45.0 % compared to the control group.

Conclusions: These antibodies may have a favorable effect on sepsis via inhibition of enzymic activity or protection of endothelial cells.

No MeSH data available.


Related in: MedlinePlus

rMuCyPA Enzymatic Characteristics and Inhibition by Anti-CsCyPAs
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
getmorefigures.php?uid=PMC4591565&req=5

Fig3: rMuCyPA Enzymatic Characteristics and Inhibition by Anti-CsCyPAs

Mentions: Comparing 0 μg rMuCyPA reaction system (control group), 1 μg rMuCyPA reaction system and 10 μg rMuCyPA reaction system, rMuCyPA showed dose-dependent improvement on reaction rate in Fig 3. This result indicated that recombinant MuCyPA possesses PPIase activity. To investigate the ability of antibodies to inhibit enzymatic activity, we co-cultured 1 μg or 10 μg antibodies with 10 μg rMuCyPA for 1 h and then continued the reaction. Comparing 10 μg rMuCyPA reaction system, 10 μg rMuCyPA with 1 μg antibodies reaction system and 10 μg rMuCyPA with 10 μg antibodies reaction system, antibodies showed significant dose-dependent inhibition.Fig 3


Prognosis of sepsis induced by cecal ligation and puncture in mice improved by anti-Clonorchis Sinensis cyclopholin a antibodies.

Song T, Yang M, Chen J, Huang L, Yin H, He T, Huang H, Hu X - Parasit Vectors (2015)

rMuCyPA Enzymatic Characteristics and Inhibition by Anti-CsCyPAs
© Copyright Policy - OpenAccess
Related In: Results  -  Collection

License 1 - License 2
Show All Figures
getmorefigures.php?uid=PMC4591565&req=5

Fig3: rMuCyPA Enzymatic Characteristics and Inhibition by Anti-CsCyPAs
Mentions: Comparing 0 μg rMuCyPA reaction system (control group), 1 μg rMuCyPA reaction system and 10 μg rMuCyPA reaction system, rMuCyPA showed dose-dependent improvement on reaction rate in Fig 3. This result indicated that recombinant MuCyPA possesses PPIase activity. To investigate the ability of antibodies to inhibit enzymatic activity, we co-cultured 1 μg or 10 μg antibodies with 10 μg rMuCyPA for 1 h and then continued the reaction. Comparing 10 μg rMuCyPA reaction system, 10 μg rMuCyPA with 1 μg antibodies reaction system and 10 μg rMuCyPA with 10 μg antibodies reaction system, antibodies showed significant dose-dependent inhibition.Fig 3

Bottom Line: Lung and mesentery tissues were stained with hematoxylin-eosin.Anti-CsCyPA antibodies could combine with MuCyPA and inhibit its peptidyl prolyl isomerase (PPIase) activity.Furthermore, the survival rate was elevated, ranging from 10.0 % to 45.0 % compared to the control group.

View Article: PubMed Central - PubMed

Affiliation: Department of Parasitology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Guangdong, China. songtianzhang@163.com.

ABSTRACT

Background: Cyclophilin A (CyPA), a ubiquitously distributed intracellular protein, is thought to be one of the important inflammatory factors and plays a significant role in the development process of sepsis. In the form of cytokine, CyPA deteriorates sepsis by promoting intercellular communication, apoptosis of endothelial cells and chemotactic effect on inflammatory cells. In our previous study, cyclophilin A of Clonorchis sinensis (CsCyPA), a type of excretory-secretory antigen, could induce the patients infected with Clonorchis sinensis to produce specific anti-CsCyPA antibodies. In this study, we investigated whether anti-CsCyPA antibodies could cross-react with CyPA and then play a protective role against sepsis, just like other anti-cytokine antagonists.

Methods: The mice model with sepsis was established with cecal ligation and puncture (CLP). Fifty mg/kg purified anti-CsCyPA antibodies were injected via the caudal vein 6 h after the CLP operation, and persistent observation was performed for 72 h. Blood samples and tissues were collected at 6 h, 12 h, 24 h, 48 h and 72 h after CLP. Cytokines in serum were measured by ELISA. Lung and mesentery tissues were stained with hematoxylin-eosin. Endothelial cells (ECs) isolated from murine aorta were co-cultured with CyPA of mice (MuCyPA) and anti-CsCyPAs for 24 h, then, viability was measured by Cell Counting Kit-8.

Results: Anti-CsCyPA antibodies could combine with MuCyPA and inhibit its peptidyl prolyl isomerase (PPIase) activity. In the antibodies treatment group, blood coagulation indicators including PT, aPTT, D-dimer and platelet count were obviously more ameliorative, the proinflammary factors like IL-6, TNF-α, IL-1β were significantly lower at 12 h and 24 h after surgery and the viability of ECs was significantly improved compared to those in the control group. Furthermore, the survival rate was elevated, ranging from 10.0 % to 45.0 % compared to the control group.

Conclusions: These antibodies may have a favorable effect on sepsis via inhibition of enzymic activity or protection of endothelial cells.

No MeSH data available.


Related in: MedlinePlus